SMI Expanded
1.739,72
PKT
-15,53
PKT
-0,88
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.12.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
| 12.12.11 | Swiss Re buy | Vontobel Research | |
| 12.12.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 09.12.11 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 09.12.11 | Nestlé halten | Independent Research GmbH | |
| 08.12.11 | Roche overweight | J.P. Morgan Cazenove | |
| 08.12.11 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
| 08.12.11 | Roche overweight | Barclays Capital | |
| 08.12.11 | Roche buy | Citigroup Corp. | |
| 08.12.11 | Holcim equal-weight | Morgan Stanley | |
| 08.12.11 | Swiss Life buy | Vontobel Research | |
| 08.12.11 | Novartis hold | Vontobel Research | |
| 07.12.11 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 07.12.11 | Zurich Insurance hold | Royal Bank of Scotland | |
| 07.12.11 | Nestlé hold | Vontobel Research | |
| 07.12.11 | Givaudan hold | Vontobel Research | |
| 07.12.11 | SGS SA buy | Vontobel Research | |
| 06.12.11 | UBS equal-weight | Morgan Stanley | |
| 06.12.11 | Zurich Insurance buy | J.P. Morgan Cazenove | |
| 06.12.11 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 06.12.11 | Swiss Re buy | Vontobel Research | |
| 06.12.11 | SGS SA buy | Vontobel Research | |
| 06.12.11 | Novartis hold | Vontobel Research | |
| 05.12.11 | Givaudan sell | Deutsche Bank AG | |
| 05.12.11 | Holcim neutral | HSBC | |
| 05.12.11 | Straumann hold | Vontobel Research | |
| 05.12.11 | SGS SA buy | Vontobel Research | |
| 02.12.11 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 02.12.11 | Zurich Insurance hold | Commerzbank Corp. & Markets | |
| 02.12.11 | Zurich Insurance buy | Nomura | |
| 02.12.11 | Holcim sell | ING | |
| 02.12.11 | Holcim buy | ING | |
| 02.12.11 | Tecan (N) hold | Vontobel Research | |
| 02.12.11 | Zurich Insurance buy | Vontobel Research | |
| 02.12.11 | Temenos buy | Vontobel Research | |
| 01.12.11 | Adecco SA buy | ING | |
| 01.12.11 | Novartis neutral | Citigroup Corp. | |
| 01.12.11 | Zurich Insurance buy | Vontobel Research | |
| 30.11.11 | Swiss Prime Site hold | Vontobel Research | |
| 29.11.11 | Novartis underperform | Cheuvreux SA |